Healthcare Marketing Blogs
09|02|26
Beyond AI-Enabled: Why a New Partner Model Is Vital for Pharmaceutical Marketing in Europe
European pharmaceutical marketers are navigating a uniquely complex landscape, balancing diverse healthcare systems, regulatory environments and market-specific needs. As AI continues to transform commercialization, the conversation must move beyond efficiency gains and automation toward a more fundamental question: what should the future client-agency partnership look like? In this POV, Michael Le Brocq, Global Head of […]
08|31|26
Beyond the Single Click-Out: Snapchat Opens the Door to Branded Rx
For years, pharmaceutical marketers have faced a challenge on Snapchat: balancing engaging branded content with the disclosure requirements necessary for compliant Rx advertising. That may be changing. In a new POV, Ali Hudson, Media Director, Paid Social, and Juniper Valeo, Director, Social Media, explore Snapchat’s newly announced multi-CTA attachments product, which allows brands to pair […]
08|06|26
What ChatGPT Ads Mean for Pharma Search
Explore the critical differences between ChatGPT Ads and standard search, the unique regulatory challenges ahead, and the exact steps pharma brands must take now to prepare for inevitable platform access.
08|04|26
From Outputs to Outcomes: Mike Guarino on the Future of Commercialization
What does it take to be a true "category of one" in today's rapidly evolving healthcare landscape? In this Fierce Pharma interview, EVERSANA INTOUCH CEO Mike Guarino discusses the shift from outputs to outcomes, the growing role of AI in commercialization, and why the competitive advantage isn't data alone, but the stories it helps brands tell. Watch the interview excerpt to hear his perspective on the future of healthcare commercialization.
07|30|26
Preparing for FDA’s Proposed DTC Broadcast Overhaul
A proposed FDA rule could significantly reshape the future of direct-to-consumer (DTC) pharmaceutical advertising, prompting life sciences brands to rethink how they reach and engage patients. In our latest point of view, Dave Leitner, EVP, Head of Media, explores the potential impact of the FDA’s proposal to eliminate the long-standing “adequate provision” standard for broadcast […]
07|09|26
Human Scarcity in an AI-First World: Cannes Lions 2026
In a world flooded with AI-generated content, the brands that stand out are proving their humanity. Discover five insights from Cannes Lions 2026 that every pharma marketer should know.
07|06|26
Beyond the AI Hype: Why Authentic Connection Dominated Cannes 2026
At Cannes Lions 2026, the conversation wasn't about replacing humans with AI—it was about amplifying what makes us human. Susan Perlbachs, Chief Creative Officer, explores the rise of Human Maxing and the lessons shaping the future of creativity.
06|10|26
A New Blueprint for Brand Campaigns In Pharma Marketing
Pharma marketers can no longer rely on in-market demand alone to drive growth. In a crowded, AI-powered landscape, brands must build connection and familiarity earlier to unlock stronger performance later. This POV reveals the five pillars behind campaigns that drive real ROI.
05|21|26
Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care?
In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.
05|15|26
2026 Pharma AI Overviews Report
In the past four years, AI has altered how users and technology discover and engage with information and continues to evolve and reshape the digital landscape. To better understand this transformation, our GEO/SEO team analyzed 10,000 pharmaceutical-specific keywords, uncovering a hidden layer of AI background searches and a rapidly changing landscape where nearly 75% of keywords now trigger AI Overviews and sources shift frequently.